PMID- 11747993 OWN - NLM STAT- MEDLINE DCOM- 20020305 LR - 20190921 IS - 0898-6568 (Print) IS - 0898-6568 (Linking) VI - 14 IP - 1 DP - 2002 Jan TI - The P2X(7) receptor-mediated phospholipase D activation is regulated by both PKC-dependent and PKC-independent pathways in a rat brain-derived Type-2 astrocyte cell line, RBA-2. PG - 83-92 AB - The aim of this study was to characterize the regulatory mechanisms of the P2X(7) receptor (P2X(7)R)-mediated phospholipase D (PLD) activation in a rat brain-derived Type-2 astrocyte cell line, RBA-2. A time course study revealed that activation of P2X(7)R resulted in a choline and not phosphorylcholine formation, suggesting that activation of P2X(7)R is associated with the phosphatidylcholine-PLD (PC-PLD) in these cells. GF 109203X, a selective protein kinase C (PKC) inhibitor, partially inhibited the P2X(7)R-mediated PLD activation, while blocking the phorbol 12-myristate 13-acetate (PMA)-stimulated PLD activity. In addition, PMA synergistically activated the P2X(7)R-mediated PLD activity. Furthermore, genistein, a tyrosine kinase inhibitor, blocked the P2X(7)R-activated PLD, while KN62, a Ca(2+)/calmodulin-dependent protein kinase II (CaMKII) inhibitor, was less effective, whereas the mitogen-activated protein kinase (MAPK) inhibitor PD98059 was ineffective. No additive inhibitory effects were found by simultaneous treatment of GF 109203X and KN62 on P2X(7)R-activated PLD. Taken together, these results demonstrate that both PKC-dependent and PKC-independent signaling pathways are involved in the regulation of P2X(7)R-mediated PLD activation. Additionally, CaMKII may participate in the PKC-dependent pathway, and tyrosine kinase may play a pivotal role on both PKC-dependent and PKC-independent pathways in the P2X(7)R-mediated PLD activation in RBA-2 cells. FAU - Hung, Amos C AU - Hung AC AD - Institute of Neuroscience, College of Life Science, National Yang Ming University, No. 155, Section 2, Li-Non Street, Shi-Pai, Taipei 112, Taiwan, ROC. FAU - Sun, Synthia H AU - Sun SH LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - England TA - Cell Signal JT - Cellular signalling JID - 8904683 RN - 0 (Enzyme Inhibitors) RN - 0 (Indoles) RN - 0 (Maleimides) RN - 0 (P2rx7 protein, rat) RN - 0 (Purinergic P2 Receptor Agonists) RN - 0 (RNA, Messenger) RN - 0 (Receptors, Purinergic P2) RN - 0 (Receptors, Purinergic P2X7) RN - 8L70Q75FXE (Adenosine Triphosphate) RN - EC 2.7.10.1 (Protein-Tyrosine Kinases) RN - EC 2.7.11.13 (Protein Kinase C) RN - EC 2.7.11.17 (Calcium-Calmodulin-Dependent Protein Kinase Type 2) RN - EC 2.7.11.17 (Calcium-Calmodulin-Dependent Protein Kinases) RN - EC 3.1.4.- (Type C Phospholipases) RN - EC 3.1.4.3 (phosphatidylcholine-specific phospholipase C) RN - EC 3.1.4.4 (Phospholipase D) RN - L79H6N0V6C (bisindolylmaleimide I) RN - NI40JAQ945 (Tetradecanoylphorbol Acetate) SB - IM MH - Adenosine Triphosphate/pharmacology MH - Animals MH - Astrocytes/drug effects/enzymology/*metabolism MH - Brain/cytology MH - Calcium-Calmodulin-Dependent Protein Kinase Type 2 MH - Calcium-Calmodulin-Dependent Protein Kinases/physiology MH - Cell Line MH - Drug Synergism MH - Enzyme Activation MH - Enzyme Inhibitors/pharmacology MH - Indoles/pharmacology MH - Kinetics MH - Maleimides/pharmacology MH - Phospholipase D/*metabolism MH - Protein Kinase C/antagonists & inhibitors/*physiology MH - Protein-Tyrosine Kinases/physiology MH - Purinergic P2 Receptor Agonists MH - RNA, Messenger/biosynthesis MH - Rats MH - Receptors, Purinergic P2/genetics/*physiology MH - Receptors, Purinergic P2X7 MH - *Signal Transduction MH - Tetradecanoylphorbol Acetate/pharmacology MH - Type C Phospholipases/metabolism EDAT- 2001/12/19 10:00 MHDA- 2002/03/07 10:01 CRDT- 2001/12/19 10:00 PHST- 2001/12/19 10:00 [pubmed] PHST- 2002/03/07 10:01 [medline] PHST- 2001/12/19 10:00 [entrez] AID - S0898656801002303 [pii] AID - 10.1016/s0898-6568(01)00230-3 [doi] PST - ppublish SO - Cell Signal. 2002 Jan;14(1):83-92. doi: 10.1016/s0898-6568(01)00230-3.